Strategies for Investors Amid Market Volatilityby Mark Eisenberg 10.08.2024Explore smart financial strategies for navigating market volatility and safeguarding your investments.
Organogenesis Q2 Revenue Surpasses Forecasts at $130Mby Mark Eisenberg 10.08.2024Organogenesis exceeds Q2 revenue expectations at $130.2M, driven by robust sales and strategic growth plans.
Nvidia Stock Faces Challenges Amid High AI Demandby Mark Eisenberg 10.08.2024Nvidia sees a 2% weekly loss despite strong AI demand, as analysts view this as a buying opportunity.
The Role of Black Philanthropy in Communityby Mark Eisenberg 09.08.2024Explore the significance of Black philanthropy in fostering community growth and cultural investment during Black Philanthropy Month.
Genpact’s Revenue Soars 6% in Q2 2024by Mark Eisenberg 09.08.2024Genpact's Q2 2024 results show 6% revenue rise, fueled by Data-Tech-AI and Digital Operations, boosting future outlook.
DOGE, Render & DIGI: Cryptocurrency Updatesby John Darbie 09.08.2024Discover the latest on DOGE's surge, Render's blockchain move, and DIGI's NFT gaming potential for investors.
China’s First 2024 Biotech Acquisition by DCTYby Lilu Anderson 09.08.2024DCTY's acquisition marks a milestone in China's biotech scene, introducing advanced TCR and CAR T-cell therapies domestically.
CFAA Ambiguity Puts AI Researchers at Riskby Lilu Anderson 09.08.2024Harvard experts debate if prompt injections in AI breach the CFAA, revealing a legal gray area.
Ethereum Faces Challenges Amid BTC and SOL Gainsby John Darbie 09.08.2024Ether struggles as spot ETFs launch, losing 28% since July.
CyberArk’s Q2 2024 Surpasses Market Expectationsby Mark Eisenberg 09.08.2024CyberArk Software sees 28% revenue growth and strong ARR boost, enhancing its leadership in identity security market.